Home › FDA clears expanded use of Pfizer's breast cancer med IBRANCE
 

Keywords :   


FDA clears expanded use of Pfizer's breast cancer med IBRANCE

2016-02-20 09:04:41| Biotech - Topix.net

The FDA approves Pfizer's supplement New Drug Application for IBRANCE . It is now cleared for the treatment of hormone receptor-positive , human epidermal growth factor receptor 2-negative advanced/metastatic breast cancer in combination with fulvestrant [AstraZeneca's FASLODEX ] in women with disease progression following endocrine therapy.

Tags: med expanded cancer breast

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
20.05GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05Pretty Little Thing warned over 'misleading' ads
20.05Several pork priorities secured in House Farm Bill
20.05BT scraps digital landline switch deadline
More »